PuraStat is a synthetic haemostatic material in the form of a prefilled syringe. PuraStat is indicated for haemostasis in the following situations encountered during surgery, when haemostasis by ligation or standard means is insufficient or impractica¹:

PuraBond is a synthetic haemostatic material in the form of a prefilled syringe, filled with a clear, aqueous peptide solution. PuraBond is part of the RADA16 family of products, alongside PuraStat. Contact between the product and liquids such as blood leads to the formation of fibres in the aqueous solution, yielding a peptide hydrogel. The hydrogel quickly coats the point of bleeding and, by physically closing the superficial part of the broken blood vessel, causes blood coagulation in the deeper part of the vascular wall, resulting in haemostasis.

PuraShield is a synthetic haemostatic material for ENT surgery. A ready-to-use, slightly viscous hydrogel, composed of self-assembling peptides (SAPs) founded by the Massachusetts Institue of Technology (MIT), whilst undergoing tissue regeneration research. PuraShield is licenced in Spain as a medical device for use in Ears, Nose, Throat, Head and Neck surgeries.
PuraShield has many advantages which lend it to being a suitable bleeding management solution for FESS, adult tonsillectomies, thyroidectomies and amongst many other types of surgery. PuraShield's composition mimics the human extracellular matrix, and it does not cause swelling of the tissue. Its transparency and viscosity ensure precise control while maintaining visibility during the surgery, even in the event of working in small and narrow spaces.